Published in Eur Respir J on January 22, 2009
Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.72
Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 1.51
COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res (2011) 1.43
Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med (2010) 1.36
Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.23
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax (2012) 1.23
Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res (2011) 1.20
The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am J Respir Crit Care Med (2010) 1.16
Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD. Respir Res (2012) 1.07
Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2010) 1.04
Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury. Front Biosci (Landmark Ed) (2012) 1.04
An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity. Front Immunol (2012) 0.98
Circulating markers of interstitial lung disease and subsequent risk of lung cancer. Cancer Epidemiol Biomarkers Prev (2011) 0.96
Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis. Chest (2011) 0.94
Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm Med (2010) 0.93
Novel outcomes and end points: biomarkers in chronic obstructive pulmonary disease clinical trials. Proc Am Thorac Soc (2011) 0.92
Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury. Lung (2013) 0.89
MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro. PLoS One (2012) 0.89
The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases. Chest (2012) 0.89
Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulm Med (2011) 0.89
Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. Br J Clin Pharmacol (2012) 0.88
Biochemical markers of aging for longitudinal studies in humans. Epidemiol Rev (2013) 0.87
Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study. PLoS One (2013) 0.86
Involvement of surfactant protein D in emphysema revealed by genetic association study. Eur J Hum Genet (2011) 0.82
Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values. Exp Ther Med (2016) 0.81
Factors influencing the measurement of plasma/serum surfactant protein D levels by ELISA. PLoS One (2014) 0.80
Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.80
Biomarkers in chronic obstructive pulmonary disease: confusing or useful? Int J Chron Obstruct Pulmon Dis (2014) 0.80
Comprehensive analysis of gene-expression profile in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.80
Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease. Respir Res (2014) 0.79
Biomarkers in airway diseases. Can Respir J (2013) 0.79
Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease. Multidiscip Respir Med (2013) 0.79
Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation. Respir Res (2014) 0.78
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. PLoS Genet (2016) 0.77
Dissociation between systemic and pulmonary anti-inflammatory effects of dexamethasone in humans. Br J Clin Pharmacol (2016) 0.77
The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease. Qatar Med J (2016) 0.76
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nat Genet (2017) 0.76
Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev (2015) 0.76
Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD). Expert Opin Ther Targets (2016) 0.76
Role of serum and induced sputum surfactant protein D in predicting the response to treatment in chronic obstructive pulmonary disease. Exp Ther Med (2014) 0.76
Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs. Biomark Insights (2016) 0.76
Airway Surfactant Protein D Deficiency in Adults With Severe Asthma. Chest (2016) 0.76
The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Proteomic differences with and without ozone-exposure in a smoking-induced emphysema lung model. Korean J Intern Med (2014) 0.75
Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients. PLoS One (2016) 0.75
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered (2003) 5.06
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J (2008) 4.53
The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med (2000) 3.08
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Heterogeneity of therapeutic responses in asthma. Br Med Bull (2000) 2.86
Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol (2000) 2.70
Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer (1991) 2.26
Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax (2008) 2.25
Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem (2000) 2.24
Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis (1989) 2.23
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
The role of domestic animals in the epidemiology of plague. II. Antibody to Yersinia pestis in sera of dogs and cats. J Infect Dis (1971) 1.99
Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Rev (1983) 1.96
Outbreak of a nosocomial infection with a strain of Proteus rettgeri resistant to many antimicrobials. Am J Clin Pathol (1974) 1.95
High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition. J Clin Endocrinol Metab (1998) 1.77
Pulmonary function and symptom responses after 6.6-hour exposure to 0.12 ppm ozone with moderate exercise. JAPCA (1988) 1.71
Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability. Invasion Metastasis (1983) 1.67
Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J Immunol (1989) 1.67
Ordering patterns and utilization of bacteriologic culture reports. Arch Intern Med (1973) 1.67
Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest (1997) 1.63
CTLA4 gene polymorphisms are associated with chronic bronchitis. Eur Respir J (2009) 1.62
Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD. COPD (2010) 1.60
Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax (2004) 1.55
Bone health is not affected by luteal phase abnormalities and decreased ovarian progesterone production in female runners. J Clin Endocrinol Metab (1997) 1.54
Quantification of skeletal alkaline phosphatase in osteoporotic serum by wheat germ agglutinin precipitation, heat inactivation, and a two-site immunoradiometric assay. Clin Chem (1994) 1.50
Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma. Chest (1999) 1.48
Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax (2004) 1.48
Comparative culture methods on 101 intravenous catheters. Routine, semiquantitative, and blood cultures. Arch Intern Med (1983) 1.47
Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax (2010) 1.46
Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program. Genet Epidemiol (2002) 1.46
EMPHYSEMA QUANTIFICATION IN A MULTI-SCANNER HRCT COHORT USING LOCAL INTENSITY DISTRIBUTIONS. Proc IEEE Int Symp Biomed Imaging (2012) 1.42
Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. Am J Respir Crit Care Med (1999) 1.39
Pulmonary effects of ozone exposure during exercise: dose-response characteristics. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.39
Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. J Virol (1994) 1.36
Reproducibility of individual responses to ozone exposure. Am Rev Respir Dis (1985) 1.35
The genetics of chronic obstructive pulmonary disease. Respir Res (2001) 1.33
Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction. Thorax (2002) 1.31
Purification of the cysB protein from Salmonella typhimurium. J Biol Chem (1987) 1.28
Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J Immunol (2000) 1.25
Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line. Cancer Res (1986) 1.20
Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease. J Virol (2000) 1.19
Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma. Int Arch Allergy Immunol (2001) 1.18
Exhaled nitric oxide in patients with asthma: association with NOS1 genotype. Am J Respir Crit Care Med (2000) 1.16
Smoking related COPD and facial wrinkling: is there a common susceptibility? Thorax (2006) 1.15
Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD. Thorax (2004) 1.15
Ozone exposure increases respiratory epithelial permeability in humans. Am Rev Respir Dis (1987) 1.14
Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor. Cancer Res (1980) 1.14
Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate. Cancer Res (1981) 1.13
Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Res (1985) 1.12
Clinical determinants of exacerbations in severe, early-onset COPD. Eur Respir J (2007) 1.11
An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts. J Biol Chem (1987) 1.11
Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides. Exp Cell Res (1994) 1.09
Amelioration of the symptoms of acute mountain sickness by staging and acetazolamide. Aviat Space Environ Med (1976) 1.09
Respiratory responses to repeated prolonged exposure to 0.12 ppm ozone. Am J Respir Crit Care Med (1994) 1.08
Spontaneous fusion between metastatic mammary tumor subpopulations. J Cell Biochem (1988) 1.08
Risk of local and systemic infections associated with umbilical vein catheterization: a prospective study in 86 newborn patients. Pediatrics (1971) 1.06
Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD. Eur Respir J (2010) 1.06
Therapeutic implications of tumor heterogeneity. Semin Oncol (1989) 1.06
Respiratory response of humans exposed to low levels of ozone for 6.6 hours. Arch Environ Health (1991) 1.05
FACS quantitation of leucine aminopeptidase and acid phosphatase on tumor-associated macrophages from metastatic and nonmetastatic mouse mammary tumors. J Leukoc Biol (1985) 1.05
The protease inhibitor PI*S allele and COPD: a meta-analysis. Eur Respir J (2005) 1.04
Body composition changes in obese and lean men during physical conditioning. Med Sci Sports (1971) 1.01
The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology (1999) 1.00
The African-American Health Project (AAHP): study overview and select findings on high risk behaviors and psychiatric disorders in African American men. Ethn Health (1997) 0.99
Application of an algorithm for the diagnosis of asthma in Chinese families: limitations and alternatives for the phenotypic assessment of asthma in family-based genetic studies. Am J Respir Crit Care Med (2000) 0.99
Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells. Mol Cell Biol (1989) 0.98
Infections and use of antimicrobials in an 800-bed hospital. Public Health Rep (1969) 0.98
Polymorphic variation in surfactant protein B is associated with COPD exacerbations. Eur Respir J (2008) 0.98
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction. Int J Clin Pract (2006) 0.97
An air quality data analysis system for interrelating effects, standards, and needed source reductions: Part 11. A lognormal model relating human lung function decrease to O3 exposure. J Air Waste Manage Assoc (1991) 0.97
Calcium fluxes in isolated acinar cells from rat parotid. Effect of adrenergic and cholinergic stimulation. J Biol Chem (1977) 0.97
Silica-induced hypertrophy of type II cells in the lungs of rats. Lab Invest (1986) 0.97
Risk factors for childhood asthma in Costa Rica. Chest (2001) 0.96
Bronchodilator responsiveness and serum total IgE levels in families of probands with severe early-onset COPD. Eur Respir J (1999) 0.96
Semiquantitative cultures and routine tip cultures on umbilical catheters. J Pediatr (1982) 0.96
Case-control association studies in pharmacogenetics. Pharmacogenomics J (2001) 0.96
Candidate genes for COPD in two large data sets. Eur Respir J (2010) 0.96
Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts. Cancer Res (1989) 0.95
Quantitation of silica-induced type II cell hyperplasia by using alkaline phosphatase histochemistry in glycol methacrylate embedded lung. Exp Lung Res (1987) 0.95
Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis. Int J Cancer (1991) 0.94
Prediction of ozone-induced FEV1 changes. Effects of concentration, duration, and ventilation. Am J Respir Crit Care Med (1997) 0.94
A comparative study of 48 host valve and 24 prosthetic valve endocarditis cases. Am Heart J (1976) 0.94
Plethysmography and impulse oscillometry assessment of tiotropium and ipratropium bromide; a randomized, double-blind, placebo-controlled, cross-over study in healthy subjects. Br J Clin Pharmacol (2006) 0.92
Alkaline phosphatase histochemistry discriminates peritubular cells in primary rat testicular cell culture. J Androl (1987) 0.90
Metabolic cooperation between mouse mammary tumor subpopulations in three-dimensional collagen gel cultures. Cancer Res (1986) 0.89
A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. Biochem Biophys Res Commun (2000) 0.89
Assessing tumor drug sensitivity by a new in vitro assay which preserves tumor heterogeneity and subpopulation interactions. J Cell Physiol Suppl (1984) 0.89
Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study. JAMA (1990) 0.88
Acclimatization to dry heat: active men vs. active women. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.87
Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha 1-proteinase inhibitor. J Clin Invest (1992) 0.87
Cardiovascular and temperature regulatory changes during progressive dehydration and euhydration. J Appl Physiol (1972) 0.87
Quantitative selectivity of contact-mediated intercellular communication in a metastatic mouse mammary tumor line. Cancer Res (1983) 0.86
Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency. Am J Epidemiol (2009) 0.86